EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,766,173 | +234.7% | 1,499,596 | +192.7% | 0.03% | +240.0% |
| Q2 2023 | $9,790,989 | -27.2% | 512,349 | -26.1% | 0.01% | -28.6% |
| Q1 2023 | $13,454,255 | -42.2% | 693,161 | -52.2% | 0.01% | -46.2% |
| Q4 2022 | $23,283,616 | -5.5% | 1,451,597 | -7.6% | 0.03% | -10.3% |
| Q3 2022 | $24,640,000 | -33.5% | 1,571,452 | -11.6% | 0.03% | -32.6% |
| Q2 2022 | $37,027,000 | +29.9% | 1,778,431 | +41.4% | 0.04% | +59.3% |
| Q1 2022 | $28,505,000 | -12.9% | 1,257,421 | -29.8% | 0.03% | 0.0% |
| Q4 2021 | $32,739,000 | +108.2% | 1,790,979 | +140.8% | 0.03% | +92.9% |
| Q3 2021 | $15,725,000 | +271.1% | 743,820 | +219.9% | 0.01% | +250.0% |
| Q2 2021 | $4,237,000 | -57.8% | 232,503 | -47.7% | 0.00% | -60.0% |
| Q1 2021 | $10,038,000 | +6.1% | 444,347 | -5.8% | 0.01% | +25.0% |
| Q4 2020 | $9,465,000 | -35.2% | 471,606 | -21.0% | 0.01% | -46.7% |
| Q3 2020 | $14,598,000 | +13.3% | 597,047 | +10.0% | 0.02% | 0.0% |
| Q2 2020 | $12,885,000 | +8.4% | 542,772 | -21.3% | 0.02% | -21.1% |
| Q1 2020 | $11,884,000 | -48.6% | 690,097 | -47.4% | 0.02% | -26.9% |
| Q4 2019 | $23,129,000 | +59.0% | 1,312,632 | +59.6% | 0.03% | +44.4% |
| Q3 2019 | $14,543,000 | +721.6% | 822,333 | +892.9% | 0.02% | +800.0% |
| Q2 2019 | $1,770,000 | +120.1% | 82,820 | +145.1% | 0.00% | +100.0% |
| Q1 2019 | $804,000 | -65.1% | 33,794 | -71.1% | 0.00% | -66.7% |
| Q4 2018 | $2,301,000 | -75.2% | 116,978 | -77.6% | 0.00% | -72.7% |
| Q3 2018 | $9,261,000 | -74.8% | 522,612 | -69.4% | 0.01% | -77.1% |
| Q2 2018 | $36,791,000 | -5.3% | 1,709,611 | -2.5% | 0.05% | -9.4% |
| Q1 2018 | $38,858,000 | +12.3% | 1,754,310 | +54.1% | 0.05% | +12.8% |
| Q4 2017 | $34,608,000 | -33.7% | 1,138,428 | -47.1% | 0.05% | -41.2% |
| Q3 2017 | $52,186,000 | -20.5% | 2,153,786 | -19.2% | 0.08% | -25.9% |
| Q2 2017 | $65,652,000 | -18.0% | 2,665,543 | -27.9% | 0.11% | -23.4% |
| Q1 2017 | $80,061,000 | +40.5% | 3,694,507 | -3.3% | 0.14% | +45.4% |
| Q4 2016 | $56,992,000 | +43.2% | 3,822,364 | +22.8% | 0.10% | +36.6% |
| Q3 2016 | $39,798,000 | +1522.4% | 3,111,653 | +891.1% | 0.07% | +1320.0% |
| Q2 2016 | $2,453,000 | +2455.2% | 313,970 | +1208.7% | 0.01% | – |
| Q1 2016 | $96,000 | -3.0% | 23,991 | +36.3% | 0.00% | – |
| Q4 2015 | $99,000 | -51.9% | 17,607 | -68.0% | 0.00% | – |
| Q2 2015 | $206,000 | -27.2% | 54,988 | -50.0% | 0.00% | – |
| Q1 2015 | $283,000 | -47.6% | 109,963 | -70.7% | 0.00% | -100.0% |
| Q4 2014 | $540,000 | +39.9% | 375,163 | +48.8% | 0.00% | – |
| Q3 2014 | $386,000 | +37.9% | 252,198 | +205.7% | 0.00% | – |
| Q2 2014 | $280,000 | +98.6% | 82,508 | +107.6% | 0.00% | – |
| Q1 2014 | $141,000 | +131.1% | 39,744 | +297.4% | 0.00% | – |
| Q4 2013 | $61,000 | -97.3% | 10,000 | -98.0% | 0.00% | -100.0% |
| Q2 2013 | $2,251,000 | – | 495,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |